Biotech

Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada

D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.

Medications. Ilustrative.
Jerusalem Mayor Moshe Lion, IATI CEO and President Karin Mayer Rubinstein and Teva executive Mark Sabag attend the opening of MIXiii Health-Tech.IL 2026 in Jerusalem.

Israeli health-tech conference opens in Jerusalem with 1,800 participants from 40 countries

In the photo (from left): Karin Mayer Rubinstein, CEO and President of the Israel Advanced Technology Industries Association (IATI), and Dror Bin, CEO of the Israel Innovation Authority.

Israeli life sciences investments fell 40% in 2025, report found

 The four-story ‘Clore Person, with inflatable organs that are activated by climbing inside the giant statue

Startup wants to grow “headless humans” to replace lab animals


Achievement: Japanese pharma firm invests in Israeli cell startup

Japanese pharma company Astellas Venture Management invests in Israeli startup Somite AI, expanding pre-seed round with over $10 million in fundraising for innovative stem cell treatments using AI.

 The founders of Somite AI

Self-dyeing, plastic-free vegan leather can be grown from bacteria, study shows

Their new process could also theoretically be adapted to have bacteria grow materials with various patterns and vibrant colors and to make more sustainable alternatives to other textiles.

The self-dyeing vegan, plastic-free leather is  a step forward in the quest for more sustainable fashion. (Illustrative).

EmendoBio enters a licensing agreement for its gene editing technology with Anocca AB

 EmendoBio

AION Labs unveils TenAces start-up, will use AI to predict molecular glues

The company aims to improve the success rate of the discovery of treatments for a range of conditions.

 AION Labs participants work on their proposals ahead of their final presentations.

Israel’s cell-based coffee: Sustainable solution to brewing industry challenges?

Due to climate change, within the next two decades, there is an expected 50% reduction in areas suitable for growing coffee.

 Pluri's new cell-based coffee

Profuse Technology achieves 80% faster muscle growth for cultivated meat

A cultivated meat company has developed a new method for promoting muscle growth in the lab • the new technique enhances protein content by a factor of five, with tissue reaching maturity in just 48h

Profuse's 3D cultivated meat

Innovation Authority puts NIS 113 million toward Bio-Convergence development

The move is a significant step forward in Israel's goal of becoming a global leader in the bio-convergence field.

CHIP-BASED artificial organs such as this ‘liver,’ could one day replace animal experiments, researchers hope.

IL MAKIAGE invests in the future of AI cosmetics


TAU Prof. Dan Peer appointed as member of American National Academy of Engineering

The National Academy of Engineering (NAE),has announced the appointment of Prof. Dan Peer from TAU as a Member of the Academy, in recognition of his groundbreaking research.

 Prof. Dan Peer

Biomica raises $20m. to advance pipeline of microbiome-based therapeutics

The financing round will be led by Shanghai Healthcare Capital, meaning it's subject to the clearance of Chinese regulatory authorities.

 Biomica microbiome-based therapeutics